ACHV Earnings & Financial Statements
Achieve Life Sciences, Inc.
$7.00
$0.00(0.00%)
27
Overall
40
Value
30
Tech
13
Quality
Market Cap
$720.32M
Volume
1.64M
52W Range
$2.62 - $8.64
Target Price
$14.36
ACHV earnings and financial statements: Achieve Life Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ACHV Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of revenue | - | - | - | - | $33.09M |
| Operating income | - | -$39.07M | -$27.25M | -$40.80M | -$33.09M |
| EBITDA | -$53.55M | -$37.40M | -$26.73M | -$40.34M | -$32.88M |
| Net income | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M |
| EPS (diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $41.79M | $38.63M | $19.37M | $29.97M | $47.52M |
| Total liabilities | $20.27M | $17.73M | $20.82M | $21.67M | $19.47M |
| Shareholders’ equity | $21.52M | $20.90M | -$1.45M | $8.30M | $28.04M |
| Cash and equivalents | $20.93M | $12.75M | $15.55M | $24.77M | $43.02M |
| Long-term debt | $11.19M | $9.90M | $6.0K | $69.0K | $14.92M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$49.47M | -$29.77M | -$24.48M | -$37.57M | -$29.44M |
| Capital expenditure | -$3.0K | - | -$21.0K | - | - |
| Free cash flow | -$49.47M | -$29.77M | -$24.50M | -$37.57M | -$29.44M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACHV | $7.00 | 0% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Achieve Life Sciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW